Algeria vs Iran: Cause of death, by non-communicable diseases, ages 5-14, male
Algeria
39.5%
in 2021
Iran
39.3%
in 2021
Algeria rank
77th
Iran rank
78th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Algeria
- Iran
How they compare
Algeria currently reports 39.5% against 39.3% in Iran, a difference of 0.2%.
The two have swapped places 4 times across 6 shared years of data; in 2000 it was Algeria ahead.
Algeria ranks 77th and Iran ranks 78th of 185 countries.
Across the 3 decades both report, Algeria averaged higher in 2 and Iran in 1.
Head to head by decade
| Decade | Algeria | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 37.6% | 34.0% | 3.6% | Algeria |
| 2010s | 42.6% | 40.6% | 2.0% | Algeria |
| 2020s | 41.2% | 42.2% | 1.1% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Algeria or Iran?
- Algeria, at 39.5% against 39.3% in Iran as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Algeria and Iran?
- 0.2%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Iran?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Iran rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Algeria ranks 77th and Iran ranks 78th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.